-+ 0.00%
-+ 0.00%
-+ 0.00%

Citius Oncology Q4 EPS $(0.06), Inline

Benzinga·12/23/2025 21:39:51
Listen to the news
Citius Oncology (NASDAQ:CTOR) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 57.14 percent increase over losses of $(0.14) per share from the same period last year.